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Kinetics of hemodialysis: A theoretical study of the removal of
solutes in chronic renal failure compared to normal health. A theo-
retical comparison of various treatment strategies for the dialysis
of patients with chronic renal failure has been made covering a
wide mol wt spectrum (60 to 5250 daltons) of metabolites. A two-
compartment model has been used with the generation rate in the
appropriate pool. The comparison for any given metabolite is
made, keeping the same level of predicted intracellular concentra-
tion as in traditional Kiil treatments, and it is found that the
number of treatment hours per week may be reduced pro rata as
the dialyzer clearance is increased. This result is independent of the
assumed site of metabolite generation, of the distribution volumes,
and of the level of the cell wall permeability. The cyclic fluctuation
in intracellular concentration and the mean level of intracellular
concentration, in relation to the level in normal health, are both
predicted for a given metabolite to be lower if the cell wall per-
meability is assumed to be on the low side rather than on the high
side. The clinical implications of the variations in intracellular and
extracellular concentration are discussed, and considerable eleva-
tion compared to normal health is predicted for both com-
partments for large molecules,  1,000 mol wt, which are gener-
ated effectively in the extracellular compartment.
Cinétique de l'hémodialyse: Une étude théorique de Ia soustraction
de substances dissoutes au cours de l'insuflisance rénale chronique
par comparaison avec une situation normale. Une comparaison
théorique de diverses strategies de traitement par dialyse de mal-
ades atteints d'insuffisance rénale chronique a été faite en couvrant
un éventail large de poids moléculaires (60 a 5250 daltons) de
métaboljtes. Un modèle a deux compartiments a été utilisé oü Ia
gCnération des métabolites a lieu dans Ic pool adequat. La corn-
paraison, pour un métabolite quelconque, est faite en conservant Ic
même niveau de concentration intracellulaire prévisible qu'avec les
traitements habituels au moyen du Kiil. On constate que le nombre
d'heures de traitement hebdomadaire peut être réduit au fur et a
mesure que Ia clairance du dialyseur est augmentCe. Ce résultat est
indépendant du lieu présumC de formation des métabolites, des
volumes de distribution et du niveau de perméabilité de Ia paroi
cellulaire. Les fluctuations cycliques de Ia concentration in-
tracellulaire et Ic niveau moyen de concentration intracellulaire
seront tous deux inférieurs au niveau de Ia situation normale, pour
un métabolite donné, si Ia perméabilité de Ia paroi cellulaire est
plutot sur le versant bas que sur le versant haut. Les implications
cliniques des variations des concentrations intra et extracellulaires
sont discutées et des élévations considérables, par comparaison
avec Ia Situation normale, sont prévues pour les deux com-
partiments en ce qui concerne les grosses molecules,  1000 PM,
qui sont généralement produites dans Ic compartiment extra-
cellulaire.
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C = concentration
K = clearance
V = volume of fluid
compartment
= time
G = metabolite generation
rate
k = permeability X surface
area
= start of dialysis
Symbols used:
dr = dialysate recirculation
volume
n = normal health
= extracellular compart-
ment
2 = intracellular compart-
ment
d = dialyzer
r = natural kidney
A number of different criteria have been put for-
ward over the last half decade for assessing the clini-
cal effectiveness of hemodialysis and hence for opti-
mizing and comparing treatment strategies [1—4].
Babb et a! [1] postulated the "square meter-hour"
hypothesis on the assumption that retention of
"toxic" middle molecules were primarily responsible
for uremic symptoms in particular neuropathies. This
criterion stimulated the present trend towards reduc-
ing treatment times by increasing the effective area or
permeability of the membrane. Popovich and Mon-
crief [2] suggested that estimates of the predialysis
concentration of solutes for different strategies of
treatment should be compared to the steady state
concentration achieved with normal renal function,
giving the predialysis metabolite concentration ratio
(PMCR). They admitted, however, considerable un-
certainty in predicting this ratio for "middle mole-
cules," due to the lack of identification of biologically
active molecules and due to lack of information on
the level of renal clearance in normal health. In a
similar analysis, Sargent and Gotch [31 showed that
the level of residual renal function critically affected
the levels of metabolite concentration if the dialyzer
clearance rate was less than 20 ml/min. In a com-
plementary approach, Babb and colleagues [4] pro-
posed the use of a dialysis index, which they defined
as the ratio of the weight of solute removed by
dialysis and residual renal function to the weight of
solute removed by a datum treatment schedule which
was deemed to be adequate (e.g., traditional Kiil
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treatment). They demonstrated a deterioration in the
electroencephalogram of one patient as the dialysis
index fell significantly below unity.
These criteria and the ensuing conclusions were
based on a single-compartment model of the body
fluid system. The purpose of this paper is to present
an alternative and complementary analysis of various
treatment strategies for a wide spectrum of metabo-
lites based on the more realistic two-compartment
model.
Review. Using different compartment models, vari-
ous groups [5—12] have investigated the kinetics of
hemodialysis, covering a range of metabolites. The
general experience, based on the analysis of solute
concentrations in the blood during and after hemo-
dialysis of patients with chronic renal failure, is that
the capillary permeability (X surface area) is much
higher than the cell wall permeability (X surface
area) and may be regarded effectively as infinite. Val-
ues of cell wall permeability X surface area (k1,2) for
urea and creatinine are in the region of 700 150 and
400 100 mI/mm, which compare (Fig. 1) with
clearances of 150 and 130 ml/min for modern 1 m2
hemodialyzers (Table 1). The pattern for vitamin B12
and inulin is somewhat reversed in that dialyzer clear-
ances can be substantially higher, for instance, 56 and
25 mI/mm for the Rhône-Poulénc-6 (RP6) dialyzer
[14], than the values of 5 and 3.5 mI/mm obtained,
respectively, by Popovich et al [101 on a single pa-
tient. The two-pool model was found [101 to be
almost as accurate in predicting the amount of vita-
min B12 removed by hemodialysis as the more com-
plicated three- and five-pool models.
One clinical implication of the two-pool model is
that because of hold-up in the intracellular com-
partment, less solute is removed from the body than
would be predicted either by a single-pool model (k1,2
= co) or by measurements of blood solutes before
and after dialysis. For instance, for urea and creati-
nine this loss of solute removal is only about 2% [6, 9,
12], and in view of the poor correlation between
predialysis concentrations of these solutes and the
general health of patients with chronic renal failure
[16-18], this loss is not considered to be important.
By contrast, for vitamin B12, taking data from Refer-
a Figures similar to these cell wall values were obtained for the
peritoneum membrane by Babb et al [15].
Creatinine
o Popovich et al, 1975 [10)
V Christopher et al, 1972 [8]
Bell et al, 1965 [5]
o Frost, 1975 [9]
'' Barsotti & Giovannetti, 1975 [20]
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Fig. 1. Effect of mol wt on cell wa/I mass transfer coefficient, k,,2. (permeability X surface area)
and on hemodialyzer clearance (shaded area). Value of k,,, for methylguanidine (MG) was ob-
tained from Barsotti and Giovannetti's analysis of data in Reference 20. CCI = creatinine
chloride.
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ence 10, it is about 50%, a factor which cannot be
ignored in predicting the effectiveness of treatment.
Gotch [19] has found that the single-pool model is
very unrealistic for studying the kinetics of peptides,
while Barsotti and Giovannetti [20] have come to the
same conclusion for methylguanidine which is partly
attributable to protein-binding. These considerations
led Popovich et al [10] to suggest that the square
meter-hour hypothesis was invalid.
Proposed criterion for treatment strategy and pa-
tient model. The other important clinical implication
of the two-pool model is that the intracellular con-
centration of any metabolite will always be different
from the blood concentration to a degree dependent
on the assumed site of metabolite generation within
the two-pool model and on the cell wall 'permeability.
If, for instance, this site is assumed to b in the main
bulk of the intracellular fluid volume, then the in-
tracellular concentration will always be higher than
the concentration in the extracellular fluid volume.
Barsotti and Giovannetti [201 have demonstrated this
effect for creatinine and methylguanidine by plasma
and muscle measurements on anuric dogs. This dis-
equilibrium is accentuated during fast removal of a
metabolite by hemodialysis with a large surface area
or highly permeable membranes. Since it is inside
body cells that toxicity of a metabolite will usually
manifest itself, most likely by enzyme inhibition [21],
it is proposed here to use the predicted intracellular
Table 1. Clearance (Kd) (mi/mm) of solutes of differing mol wt
for various dialyzers
1 m2
Multipoint, 2 m2
1 m 1.5 m2 I m2 Multi-
KiiI Ultraflo = 2 RP6 pointe
Clearance (Kd)
ml/min
60(urea) 100 140 150 (185)
73 (methyl-
guanidine) 80C 115b -—
120(creatinine 80 115 130 (155)
600 40 60 80 (100)
1350 (i.e.,
vit. B,2) 18.7 28 56 (56)
5250 (i.e.,
inulin) 8 12 25 (25)
Treatments/weeke 2
(i.e., pre
1969
standard)
3
(i.e., post 1969 standard)
At 200 and 500 mI/mm blood and dialysate flow in vivo (data
sources from References 13 and 14).
b Estimated.
Physiological parameters are: total body wt = 33 and 40 liters,
extracellular fluid 0.34 and 0.5.
total body wt
concentration of a middle molecule as a basis for
comparing treatment stategies. Specifically, we pro-
pose to use the mean of the pre- and postdialysis
concentration and to compare it to the predicted
steady state concentration in the intracellular com-
partment for normal health. This mean approximates
to the mean taken across a cycle of treatment, and the
resulting ratio will be called the "cycle average in-
tracellular metabolite concentration ratio" (CIMCR)
in contrast to the single-pool parameter (predialysis
metabolite concentration ratio) (PMCR) used by Po-
povich et al [lO].b Thus,
(pre-D intracellular conc.)
+
CIMCR = (post-D intracellular conc.)
2 X intracellular concentration
in normal health
(1)
In the first instance, metabolite generation will be
assumed to occur in the intracellular compartment
(e.g., as for creatinine). The resultant patient model is
shown in Fig. 2a. It is assumed that the renal clear-
ance, Kr, is effectively zero in most patients with
chronic renal failure; thus, the predicted values of
CIMCR are the maximum values that will occur. In
practice, some residual renal function is retained in
some un-nephrectomized patients [22]. In addition, it
is assumed that in uremia both the cell wall per-
meability, k1,2, and the metabolite generation rate, G,
are unchanged from their values in normal health.c
It should be noted that if the renal clearance in
normal health, Kr, is much greater than the cell wall
permeability, k1,2, (e.g., as is likely in the case of
vitamin B12), then the steady state intracellular con-
centration in normal health, C2, is largely independ-
ant of Kr and is equal to the metabolic generation
rate divided by the cell wall permeability (G/k1,2); on
the other hand, for a single pooi model, k1,2 >> Kr,
and then C2. is equal to the metabolic generation rate
divided by the renal clearance (G/Kr).
There is, however, the physiologic possibility that
the metabolite is generated in one of the small spe-
cialized organs (e.g., the liver for urea) rather than in
the general muscle mass. Since such organs are usu-
ally very well perfused with blood in relation to their
volume, production may be assumed as a first ap-
proximation to occur effectively in the extracellular
pool. Accordingly, an alternative model has also to
be considered (Fig. 2b) for which C2n = G/Kr, a
By virtue of the assumptions made (vide infra) in the calculation
of CIMCR (and PMCR), the index of dialysis for the various
treatment strategies, by the definition of Babb et al [4], is unity.
A very recent publication by Bergstrom and Furst [23] quotes
evidence that this last assumption is "wrong."
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Kr(1 +—)In normal health: C2 r-—
k12
For vitamin B12: k12 mI/mm (Popovich, 1975) (10]
Kr <120 mI/mm
Metabolite generation
rate (G)
relationship which is identical to that for a single-
pool model. Thus, the site of metabolite generation is
likely to affect significantly the predicted level of
CIMCR for large molecules (i.e., for mol wt 200
for which the cell wall permeability, k12, is less than
the dialzer clearance, Kd, in contrast to small mole-
cules with mol wt  120 for which k1,2 > Kd).
Comparison of treatment strategies: Method. A
range of dialyzer and treatment parameters has been
compared theoretically and is shown in Table 1. A
wide range of the cell wall permeability coefficent has
been covered because of the paucity of this data for
middle molecules, which is evident in Figure 1, and
because of the uncertainty of the clinical relevance of
any particular molecule. Values of k1,2 for methyl-
guanidine have been obtained by a two-pool analy-
sis of the biochemical data measured by Barsotti and
Giovannetti [20] on patients with chronic renal fail-
ure and dogs with anuria. The maximum probable
Hemodialyzer
clearar,ce (Kd)
level for other molecules has been obtained by
straightline extrapolation from the creatinine data to
the inulin data point. The minimum likely level for
mol wt > 150 has been defined by the data obtained
by Popovich and colleagues [10]. Since neither the
site of metabolic generation nor its volume of distri-
bution is known for mol wt > 200, a range of possi-
bilities has been considered. A selection of the pos-
sible combination of dialyzer and physiologic
parameters has been analyzed according to the fol-
lowing procedure for a complete treatment cycle. 1)
For a given solute an arbitrary metabolic generation
rate is used, for which the steady state intracellular
concentration in normal health is obtained from the
equations in Figure 2. 2) The equilibrium variation
of the intracellular (and extracellular) concentration
through the complete treatment cycle for a 2 X 12-hr
Kiil treatment is obtained by a computerized numer-
ical solution [9} of the basic differential equations (see
a k.
Intracellular
pool (2)
—L.+. Renal clearance (Kr)
*
Extracellular0- pool (1)
Metabolite generation
rate (G)
b
Intracellular
__________
pool (2)
In normal health: C2
Extracellular
pool (1)
*
.......J.ø.. Renal clearance (Kr)
Hemodialyzer
-0-
clearance (Kd)
Fig. 2. Two-pool patient model. a. metabolite generation in the intracellular pool,' b. metabolite
generation in the extracellular pool.
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Appendix). The same constant metabolic production
rate as in normal health is, for simplicity, assumed,
though there is some evidence for a dependence on
concentration, dietary intake, and diurnal rhythms
[9, 23, 24]. An iteration of the numerical solution is
required in order to arrive at the correct stabilized
level of concentration through the cycle; the treat-
ments are assumed to be equally spaced through the
weekly cycle. 3) The value of CIMCR is now ob-
tained from equation 1. 4) A treatment with a more
modern dialyzer of higher clearance is now analyzed
in the same basic way as for the Kiil treatment, but
the length of treatment is also adjusted iteratively so
that the same value of CIMCR is obtained; hence, a
value of the treatment hours per week for this par-
ticular modern treatment strategy is obtained.
Results of prediction (Fig. 2a model). Figure 3
shows a typical prediction over a complete cycle of
treatments for a traditional Kiil routine with parame-
ters simulating a 600 mol wt metabolite. Since the
metabolite is assumed to be generated in the in-
tracellular volume, the concentration in this volume
is always higher than in the extracellular volume and
is arranged in the iterative numerical procedure to be
the same at the end of the cycle as at the beginning.
A comparison between this traditional Ku! treat-
ment and a modern treatment (e.g., a I m2 multi-
point dialyzer, thrice weekly) is made in Figure 4.
The comparison is arranged so that the mean in-
tracellular concentration during treatment is the
same in both cases. Figure 5 shows the same com-
parison but assuming a much lower value for k1,2,
some 60% lower than the value assumed in Figure 4
but still higher than Popovich's data [10]. The hours
of treatment required per week are actually reduced
C10/C2 =0.37
10
Intracellular (2)
C
E
E0
0
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7.51
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0
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Kd = 40 m/min
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hr/week = 24
Half
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Time, hr
Fig. 3. Predicted kinetics of a 600 mol wt melaboli4e for the tradi-
tional twice weekly Kiil treatment. The maximum probable value
for k1,2 is 70 mI/mm.
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Fig. 4. Comparison between traditional Kill treatment and more
recent thrice weekly treatment with Multi-point dialyzer. The phys-
iological parameters are the same as in Figure 3.
Kd 40 mI/mm
n = 2/week
hr/week = 24
Half
0 10 20 30 40 50 60 70
Time, hr
Fig. 5. Comparison as for Figure 4 except cell wall permeability
reduced from 70 mI/mm to 30 mI/mm.
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Fig. 8. Variation of CIMCR with mol wi, with metabolite generation in the intracellular com-
partment for traditional / m2 Ku! treatment. The value of Kr = 77 mI/mm applies only to urea.
The scatter band for mol wt less than 150 daltons corresponds to the uncertainty in the value of
k1,2 quoted in Reference 9; for larger molecules the lower line corresponds to Popovich's single
patient data (Fig. 1) [10], while the upper line represents an approximate linear extrapolation
of the data given in Figure 1.
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Fig. 7. Comparison between traditional Kiil treatment with Cup-
rophan membrane and more recent treatment with acrylonitrile
membrane (Rhbne-Poulênc-RP6 dialyzer). (dialyzer clearances and
cell wall permeability are relevant to 1350 mol WI metabolite; k1,2 =
5 mI/mm, from Popovichs data on vitamin B12[10]).
k12 source
• Creatinine (Frost, 1975) [9]
• Urea (Frost, 1975) [9]
• Popovich 1975 1101
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Fig. 6. Effect of cell wall permeability (k,,2) on predicted variation of
intracellular concentration for traditional twice weekly Kill treat-
ment (dialyzer clearance relevant to 600 mol wt metabolite).
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1.0
slightly from 20 to 19. Both the normalized in-
tracellular concentration (CIMCR) and the fluctua-
tion in its level are apparently significantly lowered
by assuming a lower level for k1,2. The main reason
for this is that the predicted steady state concentra-
tion in normal health is elevated (or alternatively, the
metabolic generation rate is lower). This effect is
highlighted in Figure 6, where the intracellular con-
centrations from Figures 4 and 5 are compared with
that predicted assuming the level of k1,2 (5 mI/mm)
and obtained experimentally by Popov:[ch et al {10]
for vitamin B12. At this low level of k1,2, there is
virtually no clinically significant fluctuation in the
predicted intracellular concentration.
Figure 7 shows a comparison between the tradi-
tional Kiil treatment and a recently developed treat-
ment, the I m2 RP6 with the more permeable acrylo-
nitrile membrane, with parameters simulating a 1350
mol wt metabolite. Compared to a mol wt of 600, the
value of CIMCR is elevated from 2.0 to 2.8, assuming
a constant value of k1,2 = 5.0. The predicted variation
of CIMCR with the full spectrum of molecular
weight from various assumptions regarding the level
of k1,2 from the available data is shown in Figure 8.
It is, therefore, pertinent to examine the predicted
effect of clearance on treatment time, keeping the
intracellular concentration and metabolite generation
rate constant. This effect is demonstrated in Figure 9
for a 1350 mol wt metabolite, the lowest clearance (28
mI/mm) being representative of a 1 m2 Multi-point
flat bed dialyzer, the clearance of 56 mI/mm (i.e., X
2) representing the 1 m2 Rhône Poulénc multilayer
flat bed dialyzer with acrylonitrile membranes, and
1.5 the highest clearance of 168 (i.e., 6 times the multi-
point value) representing the ultimate that might be
achieved at normal clinical blood flows with some
magical membrane of high permeability and of large
surface area. There are three main features in this
comparison: a) the level of and fluctuation in the
g intracellular concentration is virtually independent of
clearance, b) the variation in the extracellular con-
centration from the end of one dialysis to the start of
8 the next is virtually independant of clearance, c) the
treatment time required is almost inversely propor-
. tional to the clearance, i.e., a six-fold increase in
clearance reduces the treatment time from 6.6 hr to
0.5 1.15 hr. Features b and c are virtually identical to that
which would be predicted for a single-pool model
(i.e., k1,2 = co)
Summary (Fig. 2a model). The assumption of me-
tabolite generation in the large intracellular pool re-
sults in a simple strategy requiring a constant value of
clearance X treatment time which is relatively inde-
pendent of the level of renal function in normal
health for molecules greater than 200 mol wt. For low
clearances, this strategy is identical to approximately
20 treatment hr/week for 1 m2 of Cuprophan® mem-
brane. It is necessary to see to what extent these
conclusions are affected by the alternative assump-
tion of metabolite production in the extracellular
pool (i.e., as in Fig. 2b).
Results of prediction (Fig. 2b model). Figure 10
Intracallular
k12 = 5 mI/mm (Popovich 812 Data) [10]
Total body wt (TBW) = 40 liters
ECF 05
TBW
3 treatments/week
. 2.5
E
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C
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C.)
1.5
0
.0
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a,
E
C)0
1.0
Dialyzer clearance, rn//rn/n
0 1 2 3 4 5 6 7 8 9
Time, hr
Fig. 9. Equilibrium kinetics for a wide range of hernodialyzer clear-
ance (cell wall permeability relevant to the 1,000 to 5,000 mol wt
range).
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Fig. 10. Predicted kinetics of a 1350 mol wt metabolite for traditional
Kiil treatment with metabolite generation in the extracellular com-
partment (k1,2 = 5 mI/mm). (Compare with Figure 7.)
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12 ich's data for vitamin B12 [10], so that the fluctuation
in the intracellular concentration is low and of the
same magnitude as that shown in Figure 7 for in-
tracellular metabolite generation. There the similarity
10 . ends: for first, the level of CIMCR is much higher due
to the reduced level of intracellular concentration in
normal health (contrast equations A3 to A7 and A8),
the level being directly proportional to the assumed
renal clearance, Kr, in normal health; second, the
8 extracellular concentration is generally increased in
•E relation to the intracellular concentration and is ac-
tually higher in the predialysis phase, as might be
. expected.
6 The effect of changing to modern treatment strate-
gies is shown in Figure II, which is comparable to
Figures 7 and 9. Indeed, the same result is found for a
fixed frequency of treatment as in Figure 9, namely
that the treatment time is inversely proportional to
the dialyzer clearance, Kd, that can be obtained. The
variation of CIMCR with the full spectrum of mo-
lecular weight for various assumptions regarding the
level of Kr is shown in Figure 12.
Clinical implications. The predictions, based on ei-
ther of the assumed sites of metabolite generation,
indicate that an increase in frequency, while retaining
the same clearance X treatment hr/week and the
same CIMCR, is very effective in reducing the cyclic
fluctuation in the intracellular compartment. Many
Extracellular
E
E0
0
C0
C00
00
0
.0
0
E
00
0 10 20 30 40 50 60 70 80
Time, hr
Fig. 11. Comparison between traditional treatment and more modern
treatments assuming generation of a 1350 mol wt metabolite in the
ext race/lu/ar compartment. MP represents the multi-point dialyzer;
RP represents the Rhône-Poulènc dialyzer.
shows a prediction for the traditional Kiil treatment,
assuming that the metabolite is generated in the ex-
tracellular compartment. A low value of the cell wall
permeability has been assumed, in line with Popov-
0
E
00
0000>0
0.35 to 0.50
Total body wt (TBW) = 33 liters
(Body model, Fig 2b)
cm =c20
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100
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___N!!!i___ in
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Fig. 12. Variation of CIMCR with metabolite mol WI assuming generation in the extracellular
compartment and for various levels of renal clearance in normal health (traditional 1 m2 Kiil
treatment.) The cell wall permeability k1,2 is taken from solid black line in Figure I.
Kinetics of hemodialysis 49
clinicians have, of course, attested to the benefits of
increasing the frequency of treatment on the health of
these patients [25] and on their blood chemistry [17,
18, 25, 26]. In some cases, however, the treatment
hr/week has been significantly increased.
Fluctuations in intracellular and extracellular con-
centration are undesirable from many ccnsiderations:
a) a toxic limit may be exceeded for a section of the
treatment cycle, b) feedback responses may be stimu-
lated (the "trade off" hypothesis of Bricker and col-
leagues [24]), c) it contributes to the "unphysiology
of dialysis" (Kjellstrand et at [27]).
Thus, any level of physiological parameter or treat-
ment strategy which reduces the predicted fluctuation
is of clinical benefit. For instance, the intracellular
fluctuation is only significant if the cell wall per-
meability, k1,2, is of the same order or higher than the
dialyzer clearance, that is for mol wt < 150 daltons.
Fast dialysis, however, while not affecting the in-
tracellular fluctuation if k1,2 is low, will certainly ac-
centuate the fluctuation in the extracellular com-
partment, which from c, and possibly b, may be
undesirable.
The variation of body chemistry over the spectrum
of mol wt (Figs. 8 and 12) is important from a cell
toxicity point of view.
High concentration levels relative to normal health
(i.e., X 50 and above) in both the intracellular and
extracellular compartments result from middle mole-
cules which are generated effectively in the extra-
cellular compartment and for which the renal clear-
ance in health is high and the dialyzer and membrane
cell wall permeability is low, Indeed, Gordon and
colleagues [28] have compared the plasma of patients
with chronic renal failure with that of normal people
and have shown that considerable elevation in the
1000 to 2000 mol wt range [23, 28] can occur.
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for steady state (i.e., normal health)
C2=G(+!—)
GC1 —
(A3)
(A 4)
B. Metabolite production, G, in extracellular pool [I] (Fig. 2b):
dClkLl(Cl—Cl) A5dt V2 ( )
dC1 k1,2(C2 — C1) + G — (Kd + K,.)CI
di V1
for steady state (i.e., normal health):
= C1
G
- K
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